Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine
- PMID: 38505955
- DOI: 10.1002/cpt.3198
Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine
Similar articles
-
Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches.Int J Mol Sci. 2020 Feb 1;21(3):969. doi: 10.3390/ijms21030969. Int J Mol Sci. 2020. PMID: 32024055 Free PMC article. Review.
-
Artificial intelligence and machine learning for clinical pharmacology.Br J Clin Pharmacol. 2024 Mar;90(3):629-639. doi: 10.1111/bcp.15930. Epub 2023 Nov 12. Br J Clin Pharmacol. 2024. PMID: 37845024 Review.
-
Artificial intelligence and machine learning in precision medicine: A paradigm shift in big data analysis.Prog Mol Biol Transl Sci. 2022;190(1):57-100. doi: 10.1016/bs.pmbts.2022.03.002. Epub 2022 Apr 8. Prog Mol Biol Transl Sci. 2022. PMID: 36008002
-
The use of machine learning and artificial intelligence within pediatric critical care.Pediatr Res. 2023 Jan;93(2):405-412. doi: 10.1038/s41390-022-02380-6. Epub 2022 Nov 14. Pediatr Res. 2023. PMID: 36376506 Free PMC article. Review.
-
Artificial intelligence in early drug discovery enabling precision medicine.Expert Opin Drug Discov. 2021 Sep;16(9):991-1007. doi: 10.1080/17460441.2021.1918096. Epub 2021 Jun 2. Expert Opin Drug Discov. 2021. PMID: 34075855 Review.
Cited by
-
Pharmaco-Multiomics: A New Frontier in Precision Psychiatry.Int J Mol Sci. 2025 Jan 26;26(3):1082. doi: 10.3390/ijms26031082. Int J Mol Sci. 2025. PMID: 39940850 Free PMC article. Review.
-
Navigating Recent Changes in Dosing Information: Dynamics of FDA-Approved Monoclonal Antibodies in Post-Marketing Realities.Clin Transl Sci. 2025 Jan;18(1):e70125. doi: 10.1111/cts.70125. Clin Transl Sci. 2025. PMID: 39807701 Free PMC article. Review.
-
Accelerating Parkinson's Disease drug development with federated learning approaches.NPJ Parkinsons Dis. 2024 Nov 21;10(1):225. doi: 10.1038/s41531-024-00837-5. NPJ Parkinsons Dis. 2024. PMID: 39567515 Free PMC article. Review.
-
Evolution of artificial intelligence in healthcare: a 30-year bibliometric study.Front Med (Lausanne). 2025 Jan 15;11:1505692. doi: 10.3389/fmed.2024.1505692. eCollection 2024. Front Med (Lausanne). 2025. PMID: 39882522 Free PMC article.
-
A Tutorial and Use Case Example of the eXtreme Gradient Boosting (XGBoost) Artificial Intelligence Algorithm for Drug Development Applications.Clin Transl Sci. 2025 Mar;18(3):e70172. doi: 10.1111/cts.70172. Clin Transl Sci. 2025. PMID: 40067353 Free PMC article.
References
-
- Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K. & Tekade, R.K. Artificial intelligence in drug discovery and development. Drug Discov. Today 26, 80-93 (2021).
-
- Liu, Q. et al. Landscape analysis of the application of artificial intelligence and machine learning in regulatory submissions for drug development from 2016 to 2021. Clin. Pharmacol. Ther. 113, 771-774 (2023).
-
- Liu, Q. et al. Application of machine learning in drug development and regulation: current status and future potential. Clin. Pharmacol. Ther. 107, 726-729 (2020).
-
- Bajwa, J., Munir, U., Nori, A. & Williams, B. Artificial intelligence in healthcare: transforming the practice of medicine. Future Healthc J. 8, e188-e194 (2021).
-
- Davenport, T. & Kalakota, R. The potential for artificial intelligence in healthcare. Future Healthc J. 6, 94-98 (2019).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources